Cargando…

P57. Activation of RIG-I induces immunogenic cell death

Detalles Bibliográficos
Autores principales:	Bek, S, Kreppel, D, Bscheider, M, Lin, CC, Haas, T, Poeck, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072291/ http://dx.doi.org/10.1186/2051-1426-2-S2-P31

Ejemplares similares

RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
por: Heidegger, Simon, et al.
Publicado: (2019)

P17. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells
por: Schnurr, M, et al.
Publicado: (2014)

Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
por: Bek, Sarah, et al.
Publicado: (2019)

Targeting RIG-I or STING promotes epithelial regeneration
por: Fischer, Julius C., et al.
Publicado: (2017)

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
por: Smith, Andressa A, et al.
Publicado: (2013)

Card9 controls Dectin‐1‐induced T‐cell cytotoxicity and tumor growth in mice
por: Haas, Tobias, et al.
Publicado: (2017)

RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
por: Fischer, Julius C., et al.
Publicado: (2017)

Murinization of an anti-GITR IgG2c antibody DTA-1 inhibits immunogenicity-mediated anaphylaxis in C57BL/6J mice
por: Alvarez, Hamsell, et al.
Publicado: (2015)

p57 kip2 immunohistochemistry: ancillary technique in hydatidiform moles diagnosis
por: Fernández, Jessica, et al.
Publicado: (2013)

P57 - Prognostic factors for asthma at school age in infants with atopic dermatitis
por: Tsabouri, Sophia, et al.
Publicado: (2014)

Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells
por: Fischer, Julius C., et al.
Publicado: (2019)

P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial
por: Shao, Y, et al.
Publicado: (2009)

P04.57. Music therapy in the treatment of cancer patients: a systematic review
por: Ostermann, T, et al.
Publicado: (2012)

Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2015)

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu
por: Nechaeva, Elena A, et al.
Publicado: (2015)

Viral inhibitions of PACT-induced RIG-I activation
por: Brisse, Morgan, et al.
Publicado: (2017)

P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
por: Malard, Florent, et al.
Publicado: (2021)

Fusion of CTA and CTB gene to immunogen significantly enhances the immunogenicity of DNA vaccine
por: Ren, X, et al.
Publicado: (2012)

Tumor suppressor activity of RIG-I
por: Li, Xian-Yang, et al.
Publicado: (2014)

Mutant RIG-I enhances cancer-related inflammation through activation of circRIG-I signaling
por: Song, Jia, et al.
Publicado: (2022)

P11-18. Immunogenicity of Lactobacillus gasseri-FliC as an oral mucosal vaccine adjuvant for HIV
por: Gunderson, S, et al.
Publicado: (2009)

P12-10. Immunogen utilizing the stable interaction of cytoplasmic tails of HIV-1 envelope and cores
por: Takahashi, H, et al.
Publicado: (2009)

P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen
por: Franco, D, et al.
Publicado: (2009)

RIG-I and dsRNA-Induced IFNβ Activation
por: Hausmann, Stéphane, et al.
Publicado: (2008)

Glutathion-S-Transferases (GSTs) and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
por: Ozdamar, Elcin Deniz, et al.
Publicado: (2013)

RIG-I Promotes Cell Death in Hepatocellular Carcinoma by Inducing M1 Polarization of Perineal Macrophages Through the RIG-I/MAVS/NF-κB Pathway
por: Zhou, Bei, et al.
Publicado: (2020)

Leptospirosis in the intensive care unit: a cohort of 57 patients
por: Vieira, S, et al.
Publicado: (2005)

RIG-I activation induces the release of extracellular vesicles with antitumor activity
por: Daßler-Plenker, Juliane, et al.
Publicado: (2016)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

P05.57. Developing good practice guidelines in the treatment of polycystic ovary syndrome with Chinese herbal medicine: a Delphi study
por: Lai, L, et al.
Publicado: (2012)

Resveratrol ameliorates apoptosis induced by contrast medium ioxitalamate in HK-2 human renal proximal tubule cells in vitro
por: Chen, YY, et al.
Publicado: (2014)

P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation
por: Zhang, C, et al.
Publicado: (2009)

P05-05. Enhanced immunogenicity of HIV-1 envelope glycoprotein trimers fused to CD40 ligand
por: Melchers, M, et al.
Publicado: (2009)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant
por: Sun, J, et al.
Publicado: (2009)

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1
por: Antonets, D, et al.
Publicado: (2009)

CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
por: Basaran, Rahman, et al.
Publicado: (2013)

Systems-based Analysis of RIG-I-dependent Signaling Identifies KHSRP as an Inhibitor of RIG-I Receptor Activation
por: Soonthornvacharin, Stephen, et al.
Publicado: (2017)

P02.57. Mindfulness meditation versus exercise in the prevention of acute respiratory infection, possible mechanisms of action: a randomized controlled trial
por: Zgierska, A, et al.
Publicado: (2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
por: Borthwick, NJ, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fqk1v3m0visqiii1fknucugtj9